Latest AMD Stories
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
National research foundation will host FREE seminars in Naples and Palm Beach Gardens on age-related macular degeneration to provide information on the latest research, treatment and technology for
CRESTWOOD, Ky., Nov. 20, 2014 /PRNewswire/ -- Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
BOCA RATON, Fla., Nov.
Novel Therapies Demonstrating Evidence of Superior Head-to-Head Efficacy Will Expand the Role of Adjunct Therapy, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
CMS decision will provide patients access to VisionCare's AMD telescope in surgical facilities where 80% of ophthalmic surgeries are conducted SARATOGA, Calif., Nov.
Implanted Lens System is a Novel Solution for Dry AMD Symptoms CHICAGO, October 21, 2014 /PRNewswire/ -- London Eye Hospital Pharma, a London based medical device
Ophthotech/Novartis's Fovista Will Exceed $500 Million in 2023 Sales as a Treatment for the Wet Form of the Disease, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
SARATOGA, Calif., Oct. 13, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc.
-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.